Voluntary Self-Inspection of Medicated Feed Manufacturing Facilities; Draft Compliance Policy Guide; Availability; Reopening of Comment Period, 26135 [E7-8781]
Download as PDF
Federal Register / Vol. 72, No. 88 / Tuesday, May 8, 2007 / Notices
rule and on the draft guidance
document by January 29, 2007.
Two companies requested FDA to
extend the comment period on the
proposed rule by 90 days because the
proposal presented complex medical
and scientific issues that required the
company to assemble a team of many
different specialties in order to prepare
their comments. Elsewhere in this issue
of the Federal Register, FDA is
reopening the comment period on the
proposed rule for 30 days. Because the
issues presented by the guidance
document are intertwined with those
presented by the proposed rule, FDA is
reopening the comment period on the
guidance document for the same period.
cprice-sewell on PROD1PC66 with NOTICES
II. Electronic Access
Persons interested in obtaining a copy
of the draft guidance may do so by using
the Internet. To receive the draft
guidance document entitled ‘‘Class II
Special Controls Document: Absorbable
Hemostatic Device,’’ you may either
send an e-mail request to
dsmica@fda.hhs.gov to receive an
electronic copy of the document, or
send a fax request to 240–276–3151 to
receive a hard copy. Please use the
document number 1558 to identify the
guidance you are requesting.
CDRH maintains an entry on the
Internet for easy access to information
including text, graphics, and files that
may be downloaded to a personal
computer with Internet access. Updated
on a regular basis, the CDRH home page
includes device safety alerts, Federal
Register reprints, information on
premarket submissions (including
lists of approved submissions,
approved applications, and
manufacturers’ addresses), small
manufacturer’s assistance, information
on video conferencing and electronic
submissions, Mammography Matters,
and other device-oriented information.
The CDRH Web site may be accessed at
https://www.fda.gov/cdrh. A search
capability for all CDRH guidance
documents are also available on the
Division of Dockets Management
Internet site at https://www.fda.gov/
ohrms/dockets.
III. Request for Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments on the draft guidance
document. Submit a single copy of
electronic comments or two paper
copies of any mailed comments, except
that individuals may submit one paper
copy. Comments are to be identified
with the docket number found in
brackets in the heading of this
VerDate Aug<31>2005
15:36 May 07, 2007
Jkt 211001
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Dated: April 25, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–8780 Filed 5–7–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007D–0027]
Voluntary Self-Inspection of Medicated
Feed Manufacturing Facilities; Draft
Compliance Policy Guide; Availability;
Reopening of Comment Period
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; reopening of comment
period.
SUMMARY: The Food and Drug
Administration (FDA) is reopening to
June 8, 2007, the comment period for
the notice of availability that appeared
in the Federal Register of February 12,
2007 (72 FR 6572). In the notice, FDA
requested comments on the draft
compliance policy guide on voluntary
self-inspection of medicated feed
manufacturing facilities. The agency is
taking this action in response to
requests for an extension to allow
interested persons additional time to
submit comments.
DATES: Submit written and electronic
comments by June 8, 2007.
ADDRESSES: Submit written comments
on the draft compliance policy guide to
the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.fda.gov/dockets/ecomments. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the documents.
FOR FURTHER INFORMATION CONTACT: Paul
Bachman, Center for Veterinary
Medicine (HFV–230), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–276–9225, email: Paul.Bachman@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of February
12, 2007 (72 FR 6572), FDA published
a notice of availability with a 75-day
comment period to request comments
on a draft compliance policy guide
(CPG) on voluntary self inspection of
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
26135
medicated feed manufacturing facilities.
The purpose of this CPG is intended to
provide guidance to FDA field offices on
considering, among other factors, the
conduct of self-inspections when
prioritizing inspections of medicated
feed manufacturing facilities for
compliance with Current Good
Manufacturing Practices for Medicated
Feeds regulations.
The agency has received a request for
an extension of the comment period for
the draft compliance policy guide. This
request conveyed concern that the
current 75-day comment period does
not allow sufficient time to develop a
meaningful or thoughtful response to
the compliance policy guide.
FDA has considered the request and
is reopening the comment period for the
draft compliance policy guide until June
8, 2007. The agency believes this
reopening allows adequate time for
interested persons to submit comments.
II. Request for Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments on these documents. Submit
a single copy of electronic comments or
two paper copies of any mailed
comments, except that individuals may
submit one paper copy. Comments are
to be identified with the docket number
found in brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Dated: May 1, 2007.
David Horowitz,
Assistant Commissioner for Regulatory
Affairs.
[FR Doc. E7–8781 Filed 5–7–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review—Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301) 443–1129.
E:\FR\FM\08MYN1.SGM
08MYN1
Agencies
[Federal Register Volume 72, Number 88 (Tuesday, May 8, 2007)]
[Notices]
[Page 26135]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-8781]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007D-0027]
Voluntary Self-Inspection of Medicated Feed Manufacturing
Facilities; Draft Compliance Policy Guide; Availability; Reopening of
Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; reopening of comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is reopening to June 8,
2007, the comment period for the notice of availability that appeared
in the Federal Register of February 12, 2007 (72 FR 6572). In the
notice, FDA requested comments on the draft compliance policy guide on
voluntary self-inspection of medicated feed manufacturing facilities.
The agency is taking this action in response to requests for an
extension to allow interested persons additional time to submit
comments.
DATES: Submit written and electronic comments by June 8, 2007.
ADDRESSES: Submit written comments on the draft compliance policy guide
to the Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
Submit electronic comments to https://www.fda.gov/dockets/ecomments. See
the SUPPLEMENTARY INFORMATION section for electronic access to the
documents.
FOR FURTHER INFORMATION CONTACT: Paul Bachman, Center for Veterinary
Medicine (HFV-230), Food and Drug Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240-276-9225, e-mail: Paul.Bachman@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of February 12, 2007 (72 FR 6572), FDA
published a notice of availability with a 75-day comment period to
request comments on a draft compliance policy guide (CPG) on voluntary
self inspection of medicated feed manufacturing facilities. The purpose
of this CPG is intended to provide guidance to FDA field offices on
considering, among other factors, the conduct of self-inspections when
prioritizing inspections of medicated feed manufacturing facilities for
compliance with Current Good Manufacturing Practices for Medicated
Feeds regulations.
The agency has received a request for an extension of the comment
period for the draft compliance policy guide. This request conveyed
concern that the current 75-day comment period does not allow
sufficient time to develop a meaningful or thoughtful response to the
compliance policy guide.
FDA has considered the request and is reopening the comment period
for the draft compliance policy guide until June 8, 2007. The agency
believes this reopening allows adequate time for interested persons to
submit comments.
II. Request for Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) written or electronic comments on these documents.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.
Dated: May 1, 2007.
David Horowitz,
Assistant Commissioner for Regulatory Affairs.
[FR Doc. E7-8781 Filed 5-7-07; 8:45 am]
BILLING CODE 4160-01-S